National Center for Health Statistics. Health, United States, 2011: with special features on socioeconomic status and health. Department of Health and Human Services. Hyattsville, MD 2012.
Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med. 1991;151:1359–64.
Bryne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23:16–22.
Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and White adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000;283:2253–9.
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med. 2011;154:303–9.
Kasim-Karakass SE. Ethnic differences in the insulin resistance syndrome. Am J Clin Natr. 2000;71:670–1.
Sudano JJ, Baker DW. Explaining US racial/ethnic disparities in health declines and mortality in late middle age: the role of socioeconomic status in health behaviors and health insurance. Soc Sci Med. 2006;62:909–22.
Sonnenberg GE, Krakower GR, Kissenbah AH. A novel pathway to the manifestation of metabolic syndrome. Obes Res. 2004;12:180–6.
Hug C, Lodish HF. The role of the adipocyte hormone adiponectin in cardiovascular disease. Curr Opin Pharmacol. 2005;5:129–34.
Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004;53:1–3.
Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, Aulchenko YS, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 43659 European individuals. Atherosclerosis. 2010;208:412–20.
Mackevics V, Heid IM, Wagner SA, Cip P, Doppelmayr H, Lejnieks A, et al. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in health Caucasians. Eur Jo Hum Gen. 2006;14:349–56.
Dolley G, Bertrais S, Frochot V, Bebel JF, Guerre-Millo M, Tores F, et al. Promoter adiponectin polymorphisms and waist/hip ratio variation in a prospective French adult study. In Jou Obesity. 2008;32:669–75.
Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, et al. Single-nucleotide polymorphism haplotypes in both proximal promoter and exon 3 of the APM 1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genetics. 2002;11:2607–14.
Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW. Association of adiponectin gene polymorphisms with type 2 diabetes an African American population enriched for nephropathy. Diabetes. 2009;58:499–504.
Chen G, Bentley A, Adeyemo A, Shriner D, Zhou J, Doumatey A, et al. Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans. Hum Mol Genetics. 2012;20:4530–6.
Liu C-T, Monda KL, Taylor KC, Lange L, Demerath EW, Palmas W, et al. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet. 2013;8, e1003681.
Speechia C, Scott K, Fortina P, Devoto M, Falkner B. Association of a polymorphic variant of the adiponectin gene with insulin resistance in African Americans. Clin Transl Sci. 2008; 3194–3199
Ng MC, Shriner D, Chen BH, Li J, Chen W-M, Guo X, et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 2014;10:e1004517.
Taylor Jr HA. The Jackson Heart Study; an overview. Ethn Dis. 2005;15:1–3.
Carpenter MA, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management in the Jackson Heart Study. Am J Med Sci. 2004;328i:131–44.
Musunuru K, Lettre G, Young T, Farlow DN, Pirruccello JP, Ejebe KG, et al. NHLBI candidate gene association resource. Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet. 2010;3:267–75.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–9.
Shand B, Elder P, Scott R, Frampton C, Willis J. Biovariability of plasma adiponectin. Clin Chem Lab Med. 2006;10:1264–8.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatsis model assessment: insulin resistance and beta-cell function form fasting plasma glucose and insulin concentration in men. Diabetologia. 1985;28:412–9.
Release #24; http://www.hapmap.org
deBakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genetics. 2008;17:R122–8.
Duan Q, Liu EY, Auer PL, Zhang G, Lange EM, Jun G, et al. Imputation of coding variants in African Americans: better performance using data from the exome sequencing project. Bioinformatics. 2013;29:2744–9.
Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, Ruczinski I, et al. Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet. 2009;5, e1000519.
Pattererson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, et al. Methods for high-density admixture mapping of disease genes. Am Jou Hum Genetics. 2004;74:979–1000.
Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, design and implementation of a cardiovascular gene-centric 50k SNP array for large-scale genome association studies. PLoS One. 2008;10, e3583.
Bidulescu A, Liu J, Chen Z, Hickson DA, Musani SK, Samdarshi TE, et al. Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in African Americans: the Jackson Heart Study. Fron Pub Health. 2013. doi:10.3389/fpubh.2013.00016.
Liu J, Butler KR, Buxbaum SG, Sung JH, Campbell BW, Taylor HA. Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study. Clin Endocrinol. 2009;72:32–7.
Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Gen & Inform. 2012;10:117–22.
SAS Institutes Inc, Cary North Carolina.
Cohen EM, Williams SM, Zheng W, Cai Q, Long J, Smith JR. ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and body mass index in black and white women. Obesity. 2011;19:2053–62.
Grabe N. AliBaba2;context specific identification of transcription factor binding sites. In Silico Biology. 2002;2(1):S1–15.
Ukkola O, Santaniemi M, Rankien T, Leon AS, Skinner JS, Wilmore JH, et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med. 2005;37:141–50.
Combs TP, Berg AH, Rajala MW, Klebanovs IP, Jimenez-Chillaron JC, Patti ME, et al. Sexual differentiation, pregnancy, caloric restriction and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003;52:267–76.
Nishizawa H, Shimomura I, Skisida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin on insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51:2734–41.
Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280:18073–80.
Vasseur F, Helbecque N, Lobbens S, Vassueur-Delannoy V, Dina C, Clement K, et al. Hypoadipoectinamia (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia. 2005;48:892–9.
Schwarz PE, Govindarajalu S, Towers W, Schwanebeck U, Fisher S, Vasseur F, et al. Haplotypes in the promoter region of the ADIPOQ gene as associated with increased diabetes risk in a German Caucasian population. Horm Metab Res. 2006;38:447–51.
Wassel CL, Pankow JS, Rasmussen-Torvik L, Li N, Taylor KD, Guo X, et al. Association of SNPS in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity. 2011;10(10):2053–62.
An SS, Hanley AJG, Ziegler JT, Brown WM, Haffner SM, Norris JM, et al. Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostatsis and adiposity phenotypes in the IRAS Family Study. Mol Genetics Metab. 2012;107:721–8.
Riestra P, Gebreab SY, Khan RJ, Bidulescu A, Correa A, Tekola-Ayele F, et al. Gender specific associations between ADIPOQ gene polymorphisms and adiponectin levels and obesity in the Jackson Heart Study. BMC Med Gen. 2015;10:65. doi:10.1186/s12881-015-214-x.
Tu Y, Yu Q, Fan G, Yang P, Lai Q, Yang F, et al. Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analysis. Mol and cell endo. 2014;396(1–2):1–9.
dbGAP DOI link www.ncbi.nlm.gov/gap/?item=Jackson+Heart+Study